CVE-2023-29030

Rockwell Automation ArmorStart ST Vulnerable to Cross-Site Scripting Attack

Description

A cross site scripting vulnerability was discovered in Rockwell Automation's ArmorStart ST product that could potentially allow a malicious user to view and modify sensitive data or make the web page unavailable. User interaction, such as a phishing attack, is required for successful exploitation of this vulnerability.

Remediation

Solution:

  • Customers should disable the webserver during normal use. The webserver is disabled by default and should only be enabled to modify configurations. After modifying configurations, the web server should be disabled.

Category

7.0
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.10%
Vendor Advisory custhelp.com
Affected: Rockwell Automation ArmorStart ST
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-29030?
CVE-2023-29030 has been scored as a high severity vulnerability.
How to fix CVE-2023-29030?
To fix CVE-2023-29030: Customers should disable the webserver during normal use. The webserver is disabled by default and should only be enabled to modify configurations. After modifying configurations, the web server should be disabled.
Is CVE-2023-29030 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-29030 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-29030?
CVE-2023-29030 affects Rockwell Automation ArmorStart ST.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.